<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="/3.0/style/exchange.xsl"?>
<ops:world-patent-data xmlns="http://www.epo.org/exchange" xmlns:ops="http://ops.epo.org" xmlns:xlink="http://www.w3.org/1999/xlink">
    <ops:meta name="elapsed-time" value="16"/>
    <exchange-documents>
        <exchange-document system="ops.epo.org" family-id="41217433" country="US" doc-number="2011166876" kind="A1">
            <bibliographic-data>
                <publication-reference>
                    <document-id document-id-type="docdb">
                        <country>US</country>
                        <doc-number>2011166876</doc-number>
                        <kind>A1</kind>
                        <date>20110707</date>
                    </document-id>
                    <document-id document-id-type="epodoc">
                        <doc-number>US2011166876</doc-number>
                        <date>20110707</date>
                    </document-id>
                </publication-reference>
                <classifications-ipcr>
                    <classification-ipcr sequence="1">
                        <text>G06Q  50/    00            A I                    </text>
                    </classification-ipcr>
                </classifications-ipcr>
                <patent-classifications>
                    <patent-classification sequence="1">
                        <classification-scheme office="" scheme="CPC"/>
                        <section>G</section>
                        <class>06</class>
                        <subclass>F</subclass>
                        <main-group>19</main-group>
                        <subgroup>3456</subgroup>
                        <classification-value>I</classification-value>
                    </patent-classification>
                    <patent-classification sequence="2">
                        <classification-scheme office="" scheme="CPC"/>
                        <section>G</section>
                        <class>06</class>
                        <subclass>Q</subclass>
                        <main-group>50</main-group>
                        <subgroup>22</subgroup>
                        <classification-value>I</classification-value>
                    </patent-classification>
                    <patent-classification sequence="1">
                        <classification-scheme office="US" scheme="UC"/>
                        <classification-symbol>705/2</classification-symbol>
                    </patent-classification>
                </patent-classifications>
                <application-reference doc-id="335352918">
                    <document-id document-id-type="docdb">
                        <country>US</country>
                        <doc-number>98950309</doc-number>
                        <kind>A</kind>
                    </document-id>
                    <document-id document-id-type="epodoc">
                        <doc-number>US20090989503</doc-number>
                        <date>20090424</date>
                    </document-id>
                    <document-id document-id-type="original">
                        <doc-number>12989503</doc-number>
                    </document-id>
                </application-reference>
                <priority-claims>
                    <priority-claim sequence="1" kind="national">
                        <document-id document-id-type="epodoc">
                            <doc-number>US20090989503</doc-number>
                            <date>20090424</date>
                        </document-id>
                        <document-id document-id-type="original">
                            <doc-number>61047944</doc-number>
                        </document-id>
                    </priority-claim>
                    <priority-claim sequence="2" kind="national">
                        <document-id document-id-type="epodoc">
                            <doc-number>US20080047944P</doc-number>
                            <date>20080425</date>
                        </document-id>
                        <document-id document-id-type="original">
                            <doc-number> PCT/US2009/041672</doc-number>
                        </document-id>
                    </priority-claim>
                    <priority-claim sequence="3" kind="national">
                        <document-id document-id-type="epodoc">
                            <doc-number>WO2009US41672</doc-number>
                            <date>20090424</date>
                        </document-id>
                    </priority-claim>
                </priority-claims>
                <parties>
                    <applicants>
                        <applicant sequence="1" data-format="epodoc">
                            <applicant-name>
                                <name>CELGENE CORP [US]</name>
                            </applicant-name>
                        </applicant>
                        <applicant sequence="1" data-format="original">
                            <applicant-name>
                                <name>CELGENE CORPORATION</name>
                            </applicant-name>
                        </applicant>
                    </applicants>
                    <inventors>
                        <inventor sequence="1" data-format="epodoc">
                            <inventor-name>
                                <name>CHAPMAN EDWARD J [US]</name>
                            </inventor-name>
                        </inventor>
                        <inventor sequence="2" data-format="epodoc">
                            <inventor-name>
                                <name> LINZER CHRISTOPHER J [US]</name>
                            </inventor-name>
                        </inventor>
                        <inventor sequence="1" data-format="original">
                            <inventor-name>
                                <name>CHAPMAN EDWARD J, </name>
                            </inventor-name>
                        </inventor>
                        <inventor sequence="2" data-format="original">
                            <inventor-name>
                                <name>LINZER CHRISTOPHER J</name>
                            </inventor-name>
                        </inventor>
                    </inventors>
                </parties>
                <invention-title lang="en">METHODS FOR DELIVERING A DRUG TO A PATIENT WHILE RESTRICTING ACCESS TO THE DRUG BY PATIENTS FOR WHOM THE DRUG MAY BE CONTRAINDICATED</invention-title>
                <references-cited>
                    <citation cited-phase="national-search-report" cited-by="examiner" sequence="1">
                        <patcit dnum-type="publication number" num="1">
                            <document-id document-id-type="epodoc">
                                <doc-number>US7141018</doc-number>
                            </document-id>
                            <document-id document-id-type="docdb">
                                <country>US</country>
                                <doc-number>7141018</doc-number>
                                <kind>B2</kind>
                            </document-id>
                        </patcit>
                        <category> </category>
                    </citation>
                    <citation cited-phase="national-search-report" cited-by="examiner" sequence="2">
                        <patcit dnum-type="publication number" num="2">
                            <document-id document-id-type="epodoc">
                                <doc-number>US2008091468</doc-number>
                            </document-id>
                            <document-id document-id-type="docdb">
                                <country>US</country>
                                <doc-number>2008091468</doc-number>
                                <kind>A1</kind>
                            </document-id>
                        </patcit>
                        <category> </category>
                    </citation>
                    <citation cited-phase="national-search-report" cited-by="examiner" sequence="3">
                        <nplcit num="1">
                            <text>Seehusen, Patient Practices and Beliefs Concerning Disposal
        of Medications, 2006, JABFM, Volume 19 Number 6, Page
        542-547</text>
                        </nplcit>
                        <category> </category>
                    </citation>
                    <citation cited-phase="national-search-report" cited-by="examiner" sequence="4">
                        <nplcit num="2">
                            <text>Seehusen, Patient Practices and Beliefs Concerning Disposal
        of Medications, 2006, JABFM, Volume 19 Number 6, Page 542-
        547</text>
                        </nplcit>
                        <category> </category>
                    </citation>
                </references-cited>
            </bibliographic-data>
            <abstract lang="en">
                <p>Methods for delivering a drug to a patient in need of the drug, while restricting access to the drug by patients for whom the drug may be contraindicated are disclosed. The methods are of the type in which prescriptions for the drug are filled by a pharmacy only after a computer readable storage medium has been consulted to retrieve a prescription approval code. Embodiments are provided wherein the patients are assigned to risk groups based upon the risk that taking the drug will lead to an adverse side effect, and certain additional information, such as periodic surveys and diagnostic tests probative of the ongoing risk of the side effect developing are obtained before prescriptions for the drug are approved.</p>
            </abstract>
        </exchange-document>
    </exchange-documents>
</ops:world-patent-data>